Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017, Article ID 6736239, 8 pages
https://doi.org/10.1155/2017/6736239
Research Article

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease

1University Health Network Pulmonary Hypertension Programme, Toronto General Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada
2Department of Medicine, Temple University, Philadelphia, PA, USA
3University Health Network Pulmonary Hypertension Programme, Toronto General Hospital, Toronto, ON, Canada
4University Health Network Pulmonary Hypertension Programme, Toronto General Hospital, Toronto Scleroderma Program, Toronto Western Hospital, Mount Sinai Hospital, Department of Medicine, Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

Correspondence should be addressed to Sindhu R. Johnson; ac.nhu@nosnhoj.uhdnis

Received 28 September 2016; Revised 9 December 2016; Accepted 9 January 2017; Published 14 February 2017

Academic Editor: Djuro Kosanovic

Copyright © 2017 Natalie K. Kozij et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Natalie K. Kozij, John T. Granton, Philip E. Silkoff, John Thenganatt, Shobha Chakravorty, and Sindhu R. Johnson, “Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease,” Canadian Respiratory Journal, vol. 2017, Article ID 6736239, 8 pages, 2017. https://doi.org/10.1155/2017/6736239.